Answer to Question 1
Correct Answer: 2,5
Rationale 1: This response does not answer the client's question.
Rationale 2: Darbepoetin alfa (Aranesp) is an erythropoiesis-stimulating factor.
Rationale 3: Darbepoetin alfa (Aranesp) does not increase immunity.
Rationale 4: The nurse should explain the medication in terms the client can understand.
Rationale 5: Darbepoetin alfa (Aranesp) stimulates production of red blood cells which carry oxygen. Getting additional oxygen to the tissues helps the client feel better.
Answer to Question 2
Correct Answer: 1,2,4
Rationale 1: The purpose of this therapy is to increase red blood cells which would increase hemoglobin.
Rationale 2: Since the client has more RBCs, more oxygen can be carried to tissues.
Rationale 3: This drug supports RBC production, not platelet production.
Rationale 4: Increase in activity level indicates treatment success.
Rationale 5: This treatment supports red blood cell production, not white blood cell production.
A medical assistant holds a specimen container to receive a biopsy sample.
Withdrawing Medication from Single-Dose or Multiple-Dose Vials
Intervention Model-Response to Client Misconduct
Use face cradle covers to prevent the client’s skin from touching the face cradle upholstery.
Using small, circular strokes, exfoliate the client’s neck and back.
Client’s view with visual field loss